Full-length TB4 sequesters actin monomers (G-actin) via LKKTET motif. Promotes cell migration, angiogenesis, and stem cell recruitment. Anti-inflammatory: downregulates NFκB, upregulates anti-inflammatory cytokines. Cardiac: activates epicardial progenitor cells for cardiac repair.
Studies have administered: 1.5–6mg per dose, varying frequency in tissue repair contexts
Cardiac repair: phase 2 (RegeneRx) for MI and stroke — mixed but promising signals. Wound healing: accelerated closure in multiple models. Hair: phase 2 trials for hair loss showed follicle stimulation. Dry eye: phase 3 completed with positive data.
Generally well-tolerated; injection site reactions; long-term effects under study
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Thymosin Beta-4 (Full Length) — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat